m+Medelevator.RU
← Поиск публикаций
Journal of materials chemistry. B · 2026

A vascularized modular 3D in vitro liver model to study bacterial infection and the role of associated host protein markers.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Kaur Manleen, Karki Divyanjali, Singh Neetu

Аннотация

Engineering physiologically relevant liver models that can replicate infection dynamics and enable real-time biomarker monitoring remains a critical unmet need in liver disease research and diagnostics. Here, we present a modular, vascularized 3D in vitro liver model using core-shell microscaffolds designed to emulate the hepatic sinusoidal architecture and inflammatory microenvironment. The system co-encapsulates Huh-7 hepatocytes and liver sinusoidal endothelial cells (LSECs) with HUVECs in two distinct regions of the scaffold, the core and shell, respectively, promoting endothelial-hepatocyte cross-talk and secretion of regenerative cytokines including HGF, IL-8, and G-CSF. Upon Escherichia coli infection, the model exhibited reduced albumin levels and upregulated expression of key inflammatory markers, replicating infection-induced hepatic stress. To enable temporal biomarker tracking, we integrated the microscaffold model with a label-free, three-electrode electrochemical biosensor for detecting antibody binding changes using square wave and cyclic voltammetry (SWV/CV). This allowed real-time, non-invasive quantification of IL-6, CRP, and PCT over two weeks, with high sensitivity, which was further corroborated by the standard detection method of ELISA. This bioengineered platform uniquely combines a tissue-mimetic structure, regenerative biology, and real-time biosensing, offering a powerful tool for infection modelling, sepsis diagnostics, and therapeutic screening. Its modularity and scalability position it as a bioengineered platform for studying infection dynamics and enabling pre-clinical therapeutic screening in a physiologically relevant 3D microenvironment.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты